Mixed-Methods Evaluation of Short-, Medium-, and Long-Term Outcomes Following Hip Treatment
Launched by MAYO CLINIC · Mar 21, 2025
Trial Information
Current as of April 29, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Mixed-Methods Evaluation of Short-, Medium-, and Long-Term Outcomes Following Hip Treatment," is looking to understand how effective various treatments are for children and young adults with certain hip problems, such as hip dysplasia, Legg-Calvé-Perthes disease, and avascular necrosis. The goal is to gather information about how patients feel and function both shortly after treatment and many years later.
To participate, individuals must be at least 18 years old and have been seen at Mayo Clinic for hip issues between 1975 and 2024. They also need to be willing to complete follow-up surveys. While the trial is currently active, it is not recruiting new participants at this time. Those who take part can expect to share their experiences and outcomes regarding their hip treatments, helping researchers learn more about the long-term effectiveness of these therapies.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients over the age of 18 seen for a concern of hip pathology at Mayo between 1975 and 2024
- • Patients over 18 who can be contacted for follow-up and are willing to participate.
- Exclusion Criteria:
- • Patients presenting over age 18 for hip dysplasia
- • Patients who are unwilling to complete follow up surveys.
About Mayo Clinic
Mayo Clinic is a renowned nonprofit medical practice and research institution dedicated to providing comprehensive healthcare and advancing medical knowledge through innovative research and education. With a commitment to patient-centered care, Mayo Clinic conducts numerous clinical trials aimed at exploring new therapies and improving treatment outcomes across various disciplines. Leveraging a multidisciplinary approach, the institution collaborates with leading experts and cutting-edge technology to ensure rigorous scientific standards and ethical practices in all its research endeavors. Through its trials, Mayo Clinic seeks to translate breakthroughs in science into tangible benefits for patients, fostering advancements in medicine that enhance health and quality of life.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rochester, Minnesota, United States
Patients applied
Trial Officials
Emmanouil Grigoriou, M.D.
Principal Investigator
Mayo Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported